B3GNT5 is a novel marker correlated with stem-like phenotype and poor clinical outcome in human gliomas.
Hang Yeon JeongSeo-Young ParkHyun-Jin KimSeungju MoonSeongsoo LeeSeung Ho LeeSung-Hak KimPublished in: CNS neuroscience & therapeutics (2020)
The findings suggest the central role of B3GNT5 in regulating malignancy of GBM.